{"public_id":"cl_db77752d7f7661afed4e87a4171e9023","status":"active","superseded_by_public_id":null,"corpus_id":6101497,"text":"Among patients with 6-10 years of disease duration, 30-40% with initially remitting disease developed progressive multiple sclerosis.","confidence":0.96,"paper":{"corpus_id":6101497,"title":"The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.","url":"https://sah.borca.ai/papers/6101497"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_48d7a64a40c8f34a5d1450fbda3c95ad","name":"progressive multiple sclerosis","description":"A form of multiple sclerosis in which neurological disability worsens over time.","types":["disease course"],"url":"https://sah.borca.ai/concepts/co_48d7a64a40c8f34a5d1450fbda3c95ad"},{"public_id":"co_71966efec7b61f40d3c7e6e3f0e71b9c","name":"disease duration of 6-10 years","description":"A time interval from disease onset used for subgroup analysis.","types":["time interval"],"url":"https://sah.borca.ai/concepts/co_71966efec7b61f40d3c7e6e3f0e71b9c"},{"public_id":"co_767370206fc5ce189f59fd6d7273ceb9","name":"remitting disease","description":"Disease characterized by periods of remission rather than continuous progression.","types":["disease course"],"url":"https://sah.borca.ai/concepts/co_767370206fc5ce189f59fd6d7273ceb9"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_db77752d7f7661afed4e87a4171e9023"}